Clene Inc.
NASDAQ:CLNNBiotechnology
Healthcare
$3.50 +1.35%
+$0.08 today
- Market cap
- $50.40M
- Beta
- 0.92
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$2.88
52W Low $3.25High $13.50
Volume 0.12M
Average 0.50M
Income Statement
Follow revenue through to earnings.
Revenue
$200,000.00
FY 2025 · Annual
-41.5% YoYOperating Income
-$23.08M
FY 2025 · Annual
Net Income
-$26.17M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 723K | 473K | 654K | 342K | 200K |
| Cost of Revenue | 289K | 26K | 121K | 70K | 43K |
| Gross Profit | 434K | 447K | 533K | 272K | 157K |
| Gross Margin | 60.0% | 94.5% | 81.5% | 79.5% | 78.5% |
| Research & Development | 28.42M | 31.92M | 26.66M | 20.06M | 14.01M |
| Selling, General & Admin | 18.81M | 16.16M | 14.42M | 13.31M | 9.23M |
| Operating Expenses | 50.41M | 48.86M | 41.07M | 33.37M | 23.24M |
| Depreciation & Amortization | 955K | 1.02M | 1.71M | 1.65M | 1.5M |
| EBITDA | (8.34M) | (25.6M) | (43.24M) | (33.69M) | (22M) |
| EBITDA Margin | -1153.9% | -5412.9% | -6611.8% | -9851.2% | -10998.0% |
| Operating Income | (49.98M) | (48.41M) | (40.54M) | (33.09M) | (23.08M) |
| Operating Margin | -6912.6% | -10234.5% | -6198.8% | -9676.3% | -11541.5% |
| Interest Income | 0 | 0 | 1.39M | 865K | 223K |
| Interest Expense | 870K | 3.3M | 4.56M | 4.06M | 2.68M |
| Other Income / Expenses | 39.81M | 18.49M | (8.96M) | (6.31M) | (3.09M) |
| Income Before Tax | (10.17M) | (29.92M) | (49.5M) | (39.4M) | (26.17M) |
| Pre-Tax Margin | -1406.4% | -6325.2% | -7569.4% | -11520.5% | -13086.5% |
| Income Tax Expense | (428K) | 0 | 0 | 0 | 0 |
| Net Income | (9.74M) | (29.92M) | (49.5M) | (39.4M) | (26.17M) |
| Net Margin | -1347.2% | -6325.2% | -7569.4% | -11520.5% | -13086.5% |
| EPS (Basic) | (3.16) | (4.69) | (9.43) | (5.67) | (2.65) |
| EPS (Diluted) | (3.16) | (4.69) | (9.43) | (5.67) | (2.65) |
| 3.08M | 3.26M | 5.25M | 6.95M | 9.86M | |
| 3.08M | 3.26M | 5.25M | 6.95M | 9.86M |
CLNN Earnings Waterfall · TTM
NASDAQ:CLNN · Revenue to Net Income
Key Ratios
EPS$-3.25
Gross Margin-499.1%
Net Margin-37978.2%
P/E Ratio-1.6
P/S Ratio2523.1
Analysis
$134.0K of revenue converted into -$33.5M of net income for the selected period. Gross margin is -499.1% and net margin is -37978.2%, showing how much revenue survives after costs and taxes. EPS is $-3.25, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 |
How much revenue does CLNN generate?
Clene Inc. (CLNN) reported $200,000.00 of revenue in fiscal 2025.
Is CLNN profitable?
Clene Inc. (CLNN) reported -$26.17M of net income, with a net margin of -13086.5%.
Continue the stock analysis
Jump to another research area for this company.